PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1955105
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1955105
The global bio-decontamination market is witnessing steady growth as industries and healthcare facilities focus on eliminating harmful microorganisms to prevent infection and contamination. According to Fortune Business Insights, the market was valued at USD 219.9 million in 2025 and is projected to grow to USD 228.6 million in 2026. By 2034, the market is expected to reach USD 329.3 million, registering a CAGR of 4.70% during the forecast period from 2026 to 2034.
Market Overview and Growth Drivers
Bio-decontamination is a critical process in healthcare facilities, pharmaceutical production, and medical device manufacturing. It involves the use of physical and chemical methods to eliminate harmful microorganisms and ensure sterile conditions. The rising adoption of bio-decontamination solutions is largely fueled by the increasing number of hospital admissions, surgical procedures, and the prevalence of hospital-acquired infections (HAIs). North America dominated the market in 2025 with a 34.60% share, driven by stringent infection control regulations and growing investments in healthcare decontamination processes.
Pharmaceutical and medical device manufacturers, research organizations, and hospitals are investing significantly in bio-decontamination systems to ensure sterile end products. The growing focus on launching new drugs and medical devices under strict regulatory frameworks has further increased demand. For instance, the U.S. FDA approved 53 novel drugs in 2023, compared to 37 in 2022, compelling manufacturers to implement advanced decontamination procedures to meet safety standards.
COVID-19 Impact on the Market
The COVID-19 pandemic accelerated the adoption of bio-decontamination products. Increased demand for sterilization and disinfection in healthcare and pharmaceutical settings highlighted the importance of effective decontamination solutions. Companies such as TOMI Environmental Solutions, Inc. witnessed revenue growth of 249.3% in 2020 compared to 2019, reflecting the surge in demand. Post-pandemic, market growth stabilized, with TOMI reporting 7.5% growth in 2022 compared to 2021, as product utilization normalized.
Market Trends and Technological Integration
Market players are increasingly integrating advanced technologies to enhance efficiency. For example, Telstar introduced the Safety Airlock System (SAS) with its ionized Hydrogen Peroxide (ionHP+) system in September 2023, allowing a log 6 reduction in bioburden while minimizing material degradation. Such technological innovations continue to propel market growth, catering to aseptic pharmaceutical manufacturing and research environments.
Segment Analysis
North America led the market in 2025 with a value of USD 76.02 million, driven by high hospital admissions, surgical procedures, and adoption of decontamination practices. Europe follows, with the UK and Germany markets projected at USD 11.4 million and USD 15 million by 2026, respectively. Asia Pacific is expected to register the highest CAGR, with China at USD 14.5 million, Japan at USD 18.8 million, and India at USD 7.7 million by 2026, due to growing pharmaceutical manufacturing and infection control awareness.
Key Players and Strategic Developments
The market is semi-consolidated, with major players including STERIS (U.S.), Bioquell (U.K.), TOMI Environmental Solutions, Inc. (U.S.), and Amira Srl Unipersonale (Italy). Companies are focusing on strategic collaborations, product launches, and mergers & acquisitions to expand their footprint. Notable developments include STERIS launching next-generation vaporized hydrogen peroxide systems in 2021 and TOMI partnering with Cellares in 2023 to integrate iHP technology into cell therapy manufacturing.
Conclusion
The bio-decontamination market is poised for significant growth between 2025 and 2034, driven by increasing healthcare demands, regulatory pressures, and technological advancements. While product recalls and certain operational limitations may restrain growth, the rising focus on infection control, aseptic manufacturing, and research safety will continue to drive adoption across pharmaceutical, medical device, and healthcare sectors. North America will maintain its leadership, while Asia Pacific offers high-growth opportunities due to expanding manufacturing and heightened awareness regarding contamination prevention.
Segmentation By Product
By Type
By Agent
By End User
By Region